The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

Abstract In this study, we determined the efficacy of the cell death biomarker cytokeratin 18 for diagnosing biliary tract cancer (BTC). We recruited 36 patients with BTC (Malignant group) and 45 patients with benign biliary tract disease (Benign group) for this study. We used M30 and M65 as cell de...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Mitsuru Sugimoto, Kazumichi Abe, Manabu Hayashi, Tadayuki Takagi, Rei Suzuki, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Ko Watanabe, Jun Nakamura, Hitomi Kikuchi, Yuichi Waragai, Mika Takasumi, Minami Hashimoto, Takuto Hikichi, Yoshihiro Nozawa, Hiromasa Ohira
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2018
Sujets:	Cell Death Biomarkers Biliary Tract Cancer (BTC) Biliary Cytology Malignant Group Benign Biliary Tract Disease Medicine R Science Q
Accès en ligne:	https://doaj.org/article/3a2bfe63fe304f33a6de52b0dae27cfd
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

Documents similaires